secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2024-09-18T23:59:59+00:00
Accession:  0001493152-24-037027
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience amends merger with NAYA; extends deadline to Oct 14, revised consideration
--------------------------------------------------------------------------------

- NAYA purchased 27,500 Series A preferred shares for $137,500 on Sept 16, 2024 per Securities Purchase Agreement.
- NAYA may buy up to additional 72,500 Series A shares for $362,500 before or at closing; prior breaches waived.
- Revised merger consideration: ≤19.9% of INVO common stock pre-merger plus new Series C convertible preferred.
- After stockholder approval, Series C converts to common representing ~60.1% of INVO outstanding shares.
- NAYA to transfer 85% of common stock payment shares to secured lender Five Narrow Lane LP.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315224037027/0001493152-24-037027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315224037027/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-037027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer